D'Anna Lucio, Foschi Matteo, Valente Mariarosaria, Zhang Liqun, Sacco Simona, Ornello Raffaele, Mansoor Nina, Fallon Matthew, Jaramillo Adelaida Gartner, Sponza Massimo, Gavrilovic Vladimir, Lobotesis Kyriakos, Gigli Gian Luigi, Banerjee Soma, Merlino Giovanni
Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Department of Brain Sciences, Imperial College London, London, UK.
Eur J Neurol. 2025 Jan;32(1):e70044. doi: 10.1111/ene.70044.
Although mechanical thrombectomy (MT) represents the standard of care for ischemic stroke due to large-vessel occlusion (LVO), the impact of sex on outcomes in tandem occlusions remains unclear. We investigated sex-based differences in outcomes after MT for tandem occlusions.
This multicenter observational study included consecutive patients with tandem occlusion treated with MT across three stroke centers (2021-2023). Propensity score matching was performed. Primary outcomes were the 90-day favorable functional outcome (mRS 0-2) and mRS score shift. Secondary outcomes included favorable recanalization, 24-h early neurological improvement, and NIHSS median score. Safety outcomes were post-MT intracerebral hemorrhage and 90-day mortality.
Of 635 patients (46.8% women), 289 women were matched to 289 men. There were no significant differences in primary, secondary, or safety outcomes between sexes. Subgroup analysis showed a lower rate of favorable 90-day mRS scores in women with diabetes compared to men. Women not receiving emergent carotid treatment had higher rates of favourable outcomes. No significant sex differences were found in other subgroups.
Women with anterior circulation tandem occlusions treated with MT have similar outcomes to men. However, women with diabetes and those treated with intracranial MT alone exhibited sex-specific differences. Further studies are needed to explore underlying mechanisms.
尽管机械取栓术(MT)是治疗大血管闭塞(LVO)所致缺血性卒中的标准治疗方法,但性别对串联闭塞患者预后的影响仍不明确。我们调查了MT治疗串联闭塞后基于性别的预后差异。
这项多中心观察性研究纳入了三个卒中中心(2021 - 2023年)接受MT治疗的连续串联闭塞患者。进行了倾向评分匹配。主要结局是90天良好功能预后(改良Rankin量表[mRS]评分0 - 2分)和mRS评分变化。次要结局包括良好再通、24小时早期神经功能改善以及美国国立卫生研究院卒中量表(NIHSS)中位数评分。安全性结局是MT术后颅内出血和90天死亡率。
在635例患者中(46.8%为女性),289名女性与289名男性进行了匹配。性别之间在主要、次要或安全性结局方面没有显著差异。亚组分析显示,与男性相比,糖尿病女性患者90天mRS评分良好的比例较低。未接受急诊颈动脉治疗的女性患者良好结局的发生率较高。在其他亚组中未发现显著的性别差异。
接受MT治疗的前循环串联闭塞女性患者与男性患者的预后相似。然而,糖尿病女性患者以及仅接受颅内MT治疗的女性患者表现出性别特异性差异。需要进一步研究以探索潜在机制。